Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Surgical sealant to be assessed in Europe:

This article was originally published in Clinica

Executive Summary

Cohesion Technologies of Palo Alto, California, has begun a European feasibility study to assess its new product for preventing blood leaks in cardiovascular and vascular surgery. CoSeal surgical sealant, a totally synthetic gel which polymerises at the surgical site in seconds, takes about five minutes to prepare and completely resorbs within 30 days. The product will be tested in up to 15 patients undergoing peripheral vascular surgery. Palo Alto-based Cohesion's first product, CoStasis, a surgical haemostat to treat diffuse bleeding, is already available in certain European countries and is expected to be submitted for US marketing approval by spring 1999.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077657

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel